Portfolio company
Brainomix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops artificial intelligence imaging platforms for hospitals to automate the diagnosis and treatment of stroke and lung fibrosis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BrainQuant
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
Qureight
This company develops an AI-powered imaging and data curation platform for biopharmaceutical companies to analyse clinical trial endpoints in lung and heart disease.
mediaire
This company develops artificial intelligence software for MRI scan analysis to assist radiologists in hospitals and clinics with diagnostic reporting.
Oxipit
This company develops artificial intelligence software for medical imaging to automate radiology reporting and diagnostic quality control for healthcare providers.
Icometrix
This company develops artificial intelligence software that quantifies brain scans to assist radiologists and neurologists in monitoring neurological disorders and informing clinical decisions.
AIRS Medical
This company develops artificial intelligence software that accelerates magnetic resonance imaging scans and enhances image quality for hospitals and diagnostic imaging centres.
BrainKey
The company develops an artificial intelligence platform providing three-dimensional brain scan visualisations and neurological health insights for physicians and patients.
StrokeDx
This company develops portable, non-invasive neuroimaging devices and software for rapid bedside stroke detection and monitoring for healthcare providers and emergency services.
